CTKB
Price:
$3.96
Market Cap:
$511.40M
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include...[Read more]
Industry
Medical - Devices
IPO Date
2021-07-23
Stock Exchange
NASDAQ
Ticker
CTKB
According to Cytek Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.83. This represents a change of -46.06% compared to the average of -12.66 of the last 4 quarters.
The mean historical PE Ratio of Cytek Biosciences, Inc. over the last ten years is 141.24. The current -6.83 PE Ratio has changed -583.57% with respect to the historical average. Over the past ten years (40 quarters), CTKB's PE Ratio was at its highest in in the March 2021 quarter at 5.74K. The PE Ratio was at its lowest in in the March 2020 quarter at -664.24.
Average
141.24
Median
-9.70
Minimum
-148.27
Maximum
727.36
Discovering the peaks and valleys of Cytek Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 465.89%
Maximum Annual PE Ratio = 727.36
Minimum Annual Increase = -186.69%
Minimum Annual PE Ratio = -148.27
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -9.70 | -93.11% |
| 2024 | -140.81 | 38.64% |
| 2023 | -101.56 | -119.05% |
| 2022 | 533.13 | -26.70% |
| 2021 | 727.36 | 465.89% |
| 2020 | 128.53 | -186.69% |
The current PE Ratio of Cytek Biosciences, Inc. (CTKB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-84.02
5-year avg
201.68
10-year avg
141.24
Cytek Biosciences, Inc.’s PE Ratio is less than Varex Imaging Corporation (-5.59), greater than Avanos Medical, Inc. (-16.69), less than Standard BioTools Inc. (-3.66), greater than ClearPoint Neuro, Inc. (-13.66), less than Treace Medical Concepts, Inc. (-4.30), greater than Surmodics, Inc. (-43.29), greater than CeriBell, Inc. (-11.52), greater than OrthoPediatrics Corp. (-10.64), greater than Organogenesis Holdings Inc. (-1052.98), greater than AngioDynamics, Inc. (-16.04),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.59 | $464.78M | |
| -16.69 | $1.17B | |
| -3.66 | $346.53M | |
| -13.66 | $403.06M | |
| -4.30 | $263.38M | |
| -43.29 | $614.51M | |
| -11.52 | $700.80M | |
| -10.64 | $457.71M | |
| -1052.98 | $301.10M | |
| -16.04 | $499.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytek Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cytek Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cytek Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Cytek Biosciences, Inc. (CTKB)?
What is the highest PE Ratio for Cytek Biosciences, Inc. (CTKB)?
What is the 3-year average PE Ratio for Cytek Biosciences, Inc. (CTKB)?
What is the 5-year average PE Ratio for Cytek Biosciences, Inc. (CTKB)?
How does the current PE Ratio for Cytek Biosciences, Inc. (CTKB) compare to its historical average?